DK1365765T3 - Anvendelse af antigestagener til inhibition af accelereret endometrial modning under infertilitetsbehandling - Google Patents

Anvendelse af antigestagener til inhibition af accelereret endometrial modning under infertilitetsbehandling

Info

Publication number
DK1365765T3
DK1365765T3 DK02722637T DK02722637T DK1365765T3 DK 1365765 T3 DK1365765 T3 DK 1365765T3 DK 02722637 T DK02722637 T DK 02722637T DK 02722637 T DK02722637 T DK 02722637T DK 1365765 T3 DK1365765 T3 DK 1365765T3
Authority
DK
Denmark
Prior art keywords
antigestagens
maturation during
endometrial maturation
infertility therapy
during infertility
Prior art date
Application number
DK02722637T
Other languages
English (en)
Inventor
Christa Hegele-Hartung
Holger Hess-Stumpp
Henning M Beier
Claudia Krusche
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/801,925 external-priority patent/US20020143000A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1365765T3 publication Critical patent/DK1365765T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK02722637T 2001-01-09 2002-01-09 Anvendelse af antigestagener til inhibition af accelereret endometrial modning under infertilitetsbehandling DK1365765T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75628601A 2001-01-09 2001-01-09
US09/801,925 US20020143000A1 (en) 2001-01-09 2001-03-09 Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en) 2001-01-09 2002-01-09 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (1)

Publication Number Publication Date
DK1365765T3 true DK1365765T3 (da) 2007-10-29

Family

ID=27116200

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02722637T DK1365765T3 (da) 2001-01-09 2002-01-09 Anvendelse af antigestagener til inhibition af accelereret endometrial modning under infertilitetsbehandling

Country Status (25)

Country Link
US (1) US20040152684A1 (da)
EP (1) EP1365765B1 (da)
JP (1) JP2004520411A (da)
CN (1) CN1244329C (da)
AR (1) AR032390A1 (da)
AT (1) ATE367817T1 (da)
AU (1) AU2002253488B2 (da)
BG (1) BG107977A (da)
BR (1) BR0206367A (da)
CA (1) CA2433776A1 (da)
CZ (1) CZ20031864A3 (da)
DE (1) DE60221359T2 (da)
DK (1) DK1365765T3 (da)
EE (1) EE200300321A (da)
ES (1) ES2290284T3 (da)
HK (1) HK1065953A1 (da)
HR (1) HRP20030628A2 (da)
HU (1) HUP0302632A2 (da)
IL (1) IL156729A0 (da)
MX (1) MXPA03006156A (da)
NO (1) NO20033125L (da)
NZ (1) NZ526908A (da)
PL (1) PL361689A1 (da)
SK (1) SK8612003A3 (da)
WO (1) WO2002067910A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
PL3037101T3 (pl) * 2014-12-22 2019-06-28 Ferring B.V. Terapia antagonistą receptora oksytocyny w fazie lutealnej w celu implantacji i uzyskania ciąży u kobiet poddawanych technikom wspomaganego rozrodu
EP3214092A1 (en) 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

Also Published As

Publication number Publication date
ATE367817T1 (de) 2007-08-15
BG107977A (bg) 2004-08-31
HRP20030628A2 (en) 2005-06-30
WO2002067910A2 (en) 2002-09-06
AU2002253488B2 (en) 2007-02-15
US20040152684A1 (en) 2004-08-05
AR032390A1 (es) 2003-11-05
JP2004520411A (ja) 2004-07-08
WO2002067910A3 (en) 2003-02-06
CA2433776A1 (en) 2002-09-06
IL156729A0 (en) 2004-02-08
EE200300321A (et) 2003-10-15
CN1244329C (zh) 2006-03-08
CN1496263A (zh) 2004-05-12
NZ526908A (en) 2005-07-29
SK8612003A3 (en) 2004-03-02
NO20033125L (no) 2003-09-09
NO20033125D0 (no) 2003-07-08
CZ20031864A3 (en) 2004-03-17
DE60221359T2 (de) 2008-04-17
ES2290284T3 (es) 2008-02-16
HK1065953A1 (en) 2005-03-11
MXPA03006156A (es) 2003-09-16
HUP0302632A2 (hu) 2003-11-28
DE60221359D1 (de) 2007-09-06
EP1365765A2 (en) 2003-12-03
EP1365765B1 (en) 2007-07-25
BR0206367A (pt) 2003-12-23
PL361689A1 (en) 2004-10-04

Similar Documents

Publication Publication Date Title
EE05430B1 (et) Imidasolo-5-l-2-anilino-primidiinid raku proliferatsiooni inhibitsiooni agensitena
DK1307197T3 (da) Sammensætninger til behandling af cancer indeholdende en topoisomeraseinhibitor og thalidomid
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
IL208892A0 (en) Use of hmg fragment as anti-inflammatory agents
DK1309327T3 (da) Farmaceutiske sammensætninger af østrogene midler
AU2002334969A1 (en) Use of stat-6 inhibitors as therapeutic agents
GB0025782D0 (en) Use of inhibitors
AU9092501A (en) Compositions and methods for inhibition of hiv-1 infection
DK1764111T3 (da) Vaginalt indgivne anti-dysrytmi midler til behandling af uterin dysrytmi
ITMI20001705A0 (it) Procedimento per la denitrificazione delle acque
DK1365765T3 (da) Anvendelse af antigestagener til inhibition af accelereret endometrial modning under infertilitetsbehandling
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
EP1359885A4 (en) NOS-HEMMER FOR THE TREATMENT OF WRINKLES
DK1170591T3 (da) Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midler
ZA200306122B (en) The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
DK1250148T4 (da) Anvendelse af FSH til behandling af infertilitet
NO20034246D0 (no) Enkel dose av aromataseinhibitor for behandling av ufruktbarhet
NO20025765L (no) Kombinasjonssett for behandling av malaria
AU151113S (en) Set of bathroom accessories
AU2002360614A8 (en) Methods of inhibiting fertility
DK1282418T3 (da) Anvendelse af pyrazolderivater til behandling af ufrugtbarhed
ITMI20011705A0 (it) Antiinfiammatori non asteroidei per il trattamento per via rettale dioligastenospermia
ITAN20020045A0 (it) Attrezzatura per pratica della terapia delle pietre calde
TW496143U (en) Positioning structure of leg for washbowl
DK1196184T3 (da) Sammensætninger til behandling af seksuel dysfunktion